Chemoinformaics analysis of 3,5-di-O-caffeoylquinic acid methyl ester
| Molecular Weight | 530.482 | nRot | 7 |
| Heavy Atom Molecular Weight | 504.274 | nRig | 23 |
| Exact Molecular Weight | 530.142 | nRing | 3 |
| Solubility: LogS | -2.178 | nHRing | 0 |
| Solubility: LogP | 2.42 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 12 | APOL | 70.3806 |
| nHD | 6 | BPOL | 33.8954 |
| QED | 0.129 |
| Synth | 3.86 |
| Natural Product Likeliness | 1.294 |
| NR-PPAR-gamma | 0.651 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.605 |
| HIA | 0.826 |
| CACO-2 | -6.334 |
| MDCK | 0.0000139 |
| BBB | 0.112 |
| PPB | 0.980078 |
| VDSS | 0.39 |
| FU | 0.0163433 |
| CYP1A2-inh | 0.256 |
| CYP1A2-sub | 0.047 |
| CYP2c19-inh | 0.324 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.777 |
| CYP2c9-sub | 0.907 |
| CYP2d6-inh | 0.375 |
| CYP2d6-sub | 0.251 |
| CYP3a4-inh | 0.206 |
| CYP3a4-sub | 0.169 |
| CL | 9.561 |
| T12 | 0.931 |
| hERG | 0.195 |
| Ames | 0.2 |
| ROA | 0.257 |
| SkinSen | 0.904 |
| Carcinogencity | 0.335 |
| EI | 0.033 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.837 |
| Antiviral | Yes |
| Prediction | 0.840941 |